Reset filter
Trefwoorden
Neoplasms, Benign ×
Meer tonen Trefwoorden
Inhoudsopgave
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

192 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility DRKS00009656 NCT00069745 Prostate Cancer - Eligibility

- 20/9/21 - 1 Formulier, 3 Itemgroepen, 34 Data-elementen, 2 Talen
Itemgroepen: Inclusion criteria, Exclusion criteria, Medical Concepts
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen Inclusion Criteria: - Stage D2 metastatic prostate cancer - Progression after one prior chemotherapy - ECOG Performance status equal / less than 2 - Life expectancy > 3 months - Surgical or medical castration - Adequate bone marrow, hepatic and renal functions - Informed consent Exclusion Criteria: - More than one prior chemotherapy - Prior platinum containing compounds - Prior malignancy - Prior significant RT/radionuclide therapy - Major GI surgery or GI disease affecting absorption - Disease with contraindication to steroids - Brain metastases

dataset medical therapy cancer - dataset

- 20/9/21 - 1 Formulier, 5 Itemgroepen, 41 Data-elementen, 2 Talen
Itemgroepen: Patient data, -, Therapeutic procedure , Tumor Status, Tumor Expansion
clinical cancer registry used in Münster

EGF100262 lapatinib in Squamous Cell Carcinoma Female Demography - EGF100262 Squamous Cell CaEGF100262 lapatinib in Squamous Cell Carcinoma Female Demographyrcinoma Female Demography

- 20/9/21 - 1 Formulier, 1 Itemgroep, 4 Data-elementen, 1 Taal
Itemgroep: Demography for Females
A Phase I, Open Label, Multicentre, Dose-escalation Study of Oral GW572016 in Combination with Radiation Therapy and Cisplatin in Patients with Stage III-IV Squamous Cell Carcinoma of the Head and Neck.

Cancer: Personal and Family History Protocol PhenX Toolkit

- 20/9/21 - 1 Formulier, 1 Itemgroep, 9 Data-elementen, 1 Taal
Itemgroep: PhenX - cancer - personal and family history protocol
This protocol is used to assess if the respondent and his or her biological parents, siblings, and children have had cancer. This protocol also obtains information about vital status, age, type of cancer, age at first diagnosis, and any additional cancer diagnoses. ODM derived from: https://cde.nlm.nih.gov Primary source: https://www.phenxtoolkit.org/ Recent publication: Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., and Hamilton, C.M. (2015) Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86:1.21.1-1.21.17. doi: 10.1002/0471142905.hg0121s86 Permission to publish granted by Carol M. Hamilton.

Eligibility NCT00915252 Acute Myeloid Leukemia - Eligibility

- 20/9/21 - 1 Formulier, 2 Itemgroepen, 24 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00915252

Eligibility NCT00844064 Pancreatic Neoplasms, Melanoma, Colorectal Neoplasms - Eligibility

- 20/9/21 - 1 Formulier, 2 Itemgroepen, 33 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00844064

Eligibility DRKS00000733 NCT00867672 Acute Myeloid Leukemia - Eligibility

- 20/9/21 - 1 Formulier, 2 Itemgroepen, 19 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00867672

Eligibility NCT00858364 Non-Small Cell Lung Cancer - Eligibility

- 20/9/21 - 1 Formulier, 2 Itemgroepen, 33 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00858364

CALGB: 90104 SPECIMEN SUBMISSION FORM NCT00014534

- 20/9/21 - 1 Formulier, 3 Itemgroepen, 23 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, SPECIMEN SUBMISSION
CALGB: 90104 SPECIMEN SUBMISSION FORM NCT00014534 Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E5F4A97F-274E-398C-E034-0003BA3F9857

registry GEKID dataset cancer - registry

- 20/9/21 - 1 Formulier, 3 Itemgroepen, 55 Data-elementen, 2 Talen
Itemgroepen: Angaben zur Meldestelle / Dateikopf, Angaben zur Person (Identitätsdaten), Epidemiologische Daten zum Tumor
registry GEKID dataset cancer

Eligibility DRKS00003686 NCT00761280 Anaplastic Astrocytoma - Eligibility

- 20/9/21 - 1 Formulier, 2 Itemgroepen, 47 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00761280

Eligibility DRKS00003778 NCT00749723 Recurrent Brain Tumors - Eligibility

- 20/9/21 - 1 Formulier, 1 Itemgroep, 25 Data-elementen, 2 Talen
Itemgroep: Inclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00749723

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial